31-52-21. Physician documentation of eligibility.

In order for a person to be considered an eligible patient to access an individualized investigational treatment pursuant to this article, a physician must document in writing that the person: (1) Has a life-threatening or severely debilitating illness; (2) Has, in consultation with the physician, considered all other treatment options currently approved by the United States Food and Drug Administration; (3) Has been given a recommendation by the physician for an individualized investigational treatment based on an analysis of such patient’s genomic sequence, human chromosomes, deoxyribonucleic acid, ribonucleic acid, genes, gene products such as enzymes and other types of proteins, or metabolites; and (4) Has given written informed consent for the use of the individualized investigational treatment.